D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 61 Citations 14,215 181 World Ranking 7373 National Ranking 3390

Research.com Recognitions

Awards & Achievements

2016 - Fellow, National Academy of Inventors

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Cancer

Garth Powis mainly investigates Biochemistry, Thioredoxin, Thioredoxin reductase, Glutathione peroxidase and Internal medicine. He has researched Thioredoxin in several fields, including Proliferation index, Cell biology, Cysteine and Cytosol. His Cysteine study combines topics in areas such as Stereochemistry and Active site.

Garth Powis has included themes like Ribonucleotide reductase, Glutaredoxin and Cell growth in his Thioredoxin reductase study. As a member of one scientific family, Garth Powis mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, Cancer therapy, Medical physics, Tumor biology, Cancer Imaging Program and Cancer treatment. His study focuses on the intersection of Enzyme inhibitor and fields such as Myosin light-chain kinase with connections in the field of Kinase.

His most cited work include:

  • Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-kinase (636 citations)
  • Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy (505 citations)
  • Properties and Biological Activities of Thioredoxins (391 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Biochemistry, Cell growth, Thioredoxin, Cancer research and Internal medicine. His study ties his expertise on Stereochemistry together with the subject of Biochemistry. His research on Cell growth also deals with topics like

  • Signal transduction and related Drug,
  • Cell biology which connect with Cancer cell.

His work carried out in the field of Thioredoxin brings together such families of science as Molecular biology, Gene expression, Cysteine and Apoptosis. While the research belongs to areas of Internal medicine, Garth Powis spends his time largely on the problem of Oncology, intersecting his research to questions surrounding Tumor biology. His work in Thioredoxin reductase addresses issues such as Ribonucleotide reductase, which are connected to fields such as Cytosol.

He most often published in these fields:

  • Biochemistry (37.50%)
  • Cell growth (18.33%)
  • Thioredoxin (18.33%)

What were the highlights of his more recent work (between 2012-2021)?

  • Cancer research (15.00%)
  • Cancer (9.17%)
  • Cancer cell (10.83%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Cancer research, Cancer, Cancer cell, Internal medicine and Angiogenesis. His Cancer research research includes themes of T cell, Chemokine, KRAS, Signal transduction and Gene silencing. Garth Powis interconnects RHOA and Oncology in the investigation of issues within Internal medicine.

His research integrates issues of Pet tracer, Stereochemistry and Cell growth in his study of Kinase. His research on Pet tracer often connects related areas such as Biochemistry. Much of his study explores Biochemistry relationship to Covalent bond.

Between 2012 and 2021, his most popular works were:

  • Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer. (362 citations)
  • ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation (40 citations)
  • Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target. (33 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Cancer

Garth Powis mostly deals with Cancer cell, Colorectal cancer, Internal medicine, Cell biology and Cancer. His Cancer cell research is multidisciplinary, relying on both Tumor microenvironment, Cathepsin, Cathepsin B and Proteases. His studies deal with areas such as Cellular differentiation, Oncology, Tumor biology, Genetic heterogeneity and Rash as well as Colorectal cancer.

Garth Powis has researched Oncology in several fields, including Chemotherapy regimen, Cohort study, Survival rate, Carcinoma and Melanoma. His research in Internal medicine intersects with topics in Endocrinology and Immunology. The study incorporates disciplines such as Carcinogenesis, Epithelium and Cell growth in addition to Cell biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-kinase

G Powis;R Bonjouklian;R Bonjouklian;M M Berggren;M M Berggren;A Gallegos;A Gallegos.
Cancer Research (1994)

854 Citations

Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

Jeffrey M. Arbeit;J. Martin Brown;K. S.Clifford Chao;J. Donald Chapman.
International Journal of Radiation Biology (2006)

699 Citations

The role of the redox protein thioredoxin in cell growth and cancer.

Garth Powis;Debbie Mustacich;Amy Coon.
Free Radical Biology and Medicine (2000)

601 Citations

The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice.

Larisa Nonn;Ryan R. Williams;Robert P. Erickson;Garth Powis.
Molecular and Cellular Biology (2003)

495 Citations

Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

Nathan T. Ihle;Lauren Averett Byers;Edward S. Kim;Pierre Saintigny.
Journal of the National Cancer Institute (2012)

477 Citations

Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer.

Andrzej Weichsel;John R Gasdaska;Garth Powis;William R Montfort.
Structure (1996)

442 Citations

Passing the baton: the HIF switch

Mei Yee Koh;Garth Powis.
Trends in Biochemical Sciences (2012)

428 Citations

Redox signalling and the control of cell growth and death

Garth Powis;Margaret Briehl;John Oblong.
Pharmacology & Therapeutics (1995)

384 Citations

HIF-1 regulation: not so easy come, easy go

Mei Yee Koh;Taly R. Spivak-Kroizman;Garth Powis.
Trends in Biochemical Sciences (2008)

381 Citations

Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue : effects of cigarette smoking and alcohol

John J. Schlager;Garth Powis.
International Journal of Cancer (1990)

340 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Garth Powis

Arne Holmgren

Arne Holmgren

Karolinska Institute

Publications: 63

Dean P. Jones

Dean P. Jones

Emory University

Publications: 47

Junji Yodoi

Junji Yodoi

Kyoto University

Publications: 41

Elias S.J. Arnér

Elias S.J. Arnér

Karolinska Institute

Publications: 37

David Ross

David Ross

World Health Organization

Publications: 33

Paul Workman

Paul Workman

Institute of Cancer Research

Publications: 30

Douglas R. Spitz

Douglas R. Spitz

University of Iowa

Publications: 27

Hajime Nakamura

Hajime Nakamura

Kyoto University

Publications: 27

Junqiu Liu

Junqiu Liu

Hangzhou Normal University

Publications: 24

Young-Mi Go

Young-Mi Go

Emory University

Publications: 23

Peter Wipf

Peter Wipf

University of Pittsburgh

Publications: 23

David Siegel

David Siegel

University of California, Santa Barbara

Publications: 22

Gregg L. Semenza

Gregg L. Semenza

Johns Hopkins University School of Medicine

Publications: 21

Jason M. Hansen

Jason M. Hansen

Brigham Young University

Publications: 21

Vadim N. Gladyshev

Vadim N. Gladyshev

Brigham and Women's Hospital

Publications: 20

Marcus Conrad

Marcus Conrad

Helmholtz Zentrum München

Publications: 20

Trending Scientists

Kunihiko Sadakane

Kunihiko Sadakane

University of Tokyo

Pier Luca Lanzi

Pier Luca Lanzi

Polytechnic University of Milan

Dragoš Cvetković

Dragoš Cvetković

University of Belgrade

Ernesto Ciaramella

Ernesto Ciaramella

Sant'Anna School of Advanced Studies

Chi Fai Cheung

Chi Fai Cheung

Hong Kong Polytechnic University

Stuart Licht

Stuart Licht

George Washington University

Shu Seki

Shu Seki

Kyoto University

Bert F. Sels

Bert F. Sels

KU Leuven

Alexander S. Mikheyev

Alexander S. Mikheyev

Australian National University

Andreas Ibrom

Andreas Ibrom

Technical University of Denmark

Aldina Barral

Aldina Barral

Oswaldo Cruz Foundation

Klaus Warnatz

Klaus Warnatz

University of Freiburg

Michael D. Prados

Michael D. Prados

University of California, San Francisco

Peter Jenner

Peter Jenner

King's College London

Joseph D. Tucker

Joseph D. Tucker

University of North Carolina at Chapel Hill

Frank W. Wise

Frank W. Wise

Cornell University

Something went wrong. Please try again later.